News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Warns Hospira, Inc. (HSP) Over Costa Rica Infusion Device Plant



8/29/2012 8:54:48 AM

Hospira Inc. said Tuesday it received a warning letter from the Food and Drug Administration based on a recent inspection of a medical device manufacturing facility in Costa Rice. The Lake Forest, Ill., company said it received the letter Thursday. The FDA said the facility was not complying with the agency's rules. The agency also said Hospira's initial response to the inspection was inadequate because the company has not made changes to correct problems, hasn't created proper procedures for accepting products coming in, and is not keeping adequate records of the devices it makes.

Read at CBS News
Read at CNBC
Read at Reuters


comments powered by Disqus
CBS News
CNBC
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES